See more : Intec Capital Limited (INTECCAP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Changmao Biochemical Engineering Company Limited (0954.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Changmao Biochemical Engineering Company Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. (603976.SS) Income Statement Analysis – Financial Results
- Beijing Hengyu Datacom Aviation Equipment co., LTD. (300965.SZ) Income Statement Analysis – Financial Results
- Scorpio Tankers Inc. 7.00% Seni (SBBA) Income Statement Analysis – Financial Results
- NARI Technology Co., Ltd. (600406.SS) Income Statement Analysis – Financial Results
- SYoung Group Co., Ltd. (300740.SZ) Income Statement Analysis – Financial Results
Changmao Biochemical Engineering Company Limited (0954.HK)
About Changmao Biochemical Engineering Company Limited
Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, pharmaceutical adjuvant, and active pharmaceutical ingredient, etc. The company is also involved in the research and development of medicine and nutraceutical products; production and sale of food additives; trading of organic acids; and property holding activities. Changmao Biochemical Engineering Company Limited was founded in 1992 and is headquartered in Changzhou, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 637.08M | 730.03M | 547.98M | 444.11M | 494.58M | 639.12M | 630.84M | 594.40M | 514.78M | 561.67M | 703.03M | 653.22M | 620.23M | 515.57M | 385.30M | 418.43M | 397.42M | 321.44M | 93.04M | 95.23M | 89.32M |
| Cost of Revenue | 611.27M | 549.20M | 509.30M | 341.07M | 359.43M | 509.39M | 555.85M | 488.87M | 399.95M | 450.34M | 534.02M | 525.77M | 506.05M | 378.21M | 295.96M | 328.42M | 319.56M | 217.23M | 16.63M | 17.02M | 12.34M |
| Gross Profit | 25.81M | 180.83M | 38.68M | 103.04M | 135.16M | 129.73M | 75.00M | 105.53M | 114.83M | 111.33M | 169.01M | 127.45M | 114.19M | 137.36M | 89.34M | 90.00M | 77.87M | 104.21M | 76.41M | 78.21M | 76.98M |
| Gross Profit Ratio | 4.05% | 24.77% | 7.06% | 23.20% | 27.33% | 20.30% | 11.89% | 17.75% | 22.31% | 19.82% | 24.04% | 19.51% | 18.41% | 26.64% | 23.19% | 21.51% | 19.59% | 32.42% | 82.13% | 82.12% | 86.18% |
| Research & Development | 0.00 | 13.92M | 12.65M | 11.59M | 10.30M | 8.68M | 8.12M | 8.04M | 7.53M | 8.49M | 16.00M | 13.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 74.62M | 88.55M | 73.49M | 70.89M | 60.96M | 63.55M | 62.21M | 61.96M | 59.62M | 58.97M | 69.11M | 61.36M | 52.40M | 49.33M | 38.97M | 26.04M | 23.26M | 23.88M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 8.69M | 8.42M | 8.21M | 13.93M | 14.06M | 15.17M | 18.46M | 17.96M | 15.10M | 14.20M | 15.35M | 16.25M | 12.73M | 10.03M | 8.13M | 7.64M | 7.11M | 7.02M | 0.00 | 0.00 | 0.00 |
| SG&A | 83.31M | 96.97M | 81.70M | 84.82M | 75.03M | 78.72M | 80.68M | 79.92M | 74.71M | 73.16M | 84.46M | 77.60M | 65.13M | 59.35M | 47.10M | 33.68M | 30.37M | 30.90M | 0.00 | 0.00 | 0.00 |
| Other Expenses | -5.45M | -3.48M | -4.66M | -2.85M | -3.75M | 2.36M | 2.42M | 1.36M | 1.16M | 883.00K | 207.00K | 474.00K | -5.40M | -5.02M | -10.78M | -1.79M | -2.78M | -4.77M | 33.32M | 22.43M | 38.65M |
| Operating Expenses | 77.86M | 93.49M | 77.03M | 81.97M | 71.28M | 76.01M | 67.89M | 76.78M | 71.65M | 66.22M | 82.67M | 72.57M | 59.73M | 54.33M | 36.32M | 31.89M | 27.59M | 26.13M | 33.32M | 22.43M | 38.65M |
| Cost & Expenses | 689.13M | 642.69M | 586.33M | 423.03M | 430.70M | 585.40M | 623.74M | 565.65M | 471.60M | 516.56M | 616.69M | 598.33M | 565.77M | 432.55M | 332.28M | 360.31M | 347.15M | 243.36M | 49.95M | 39.46M | 50.99M |
| Interest Income | 1.05M | 940.00K | 537.00K | 215.00K | 264.00K | 296.00K | 261.00K | 475.00K | 687.00K | 1.41M | 555.00K | 645.00K | 554.00K | 462.00K | -3.87M | -2.64M | 457.00K | 310.00K | 297.00K | 0.00 | 0.00 |
| Interest Expense | 7.58M | 2.67M | 1.95M | 62.00K | 521.00K | 1.15M | 232.00K | 111.00K | 0.00 | 4.56M | 7.51M | 10.72M | 9.30M | 6.94M | 2.75M | 8.77M | 10.95M | 5.53M | 1.91M | 1.95M | 0.00 |
| Depreciation & Amortization | 42.75M | 32.20M | 29.21M | 32.78M | 35.36M | 34.37M | 37.91M | 36.41M | 36.75M | 33.77M | 35.13M | 36.78M | 31.78M | 29.82M | 27.01M | 24.19M | 16.33M | 13.34M | 2.89M | 2.71M | 2.67M |
| EBITDA | -8.25M | 122.52M | 115.58M | 50.00M | 98.43M | 90.12M | 39.38M | 71.32M | 87.75M | 80.24M | 124.25M | 106.82M | 87.53M | 112.84M | 80.03M | 82.30M | 66.71M | 93.22M | 92.88M | 45.50M | 41.00M |
| EBITDA Ratio | -1.30% | 17.57% | -1.88% | 11.29% | 20.33% | 14.11% | 6.70% | 11.67% | 16.83% | 14.53% | 17.12% | 14.35% | 14.11% | 21.89% | 20.77% | 19.67% | 17.08% | 28.50% | 49.42% | 61.41% | 45.90% |
| Operating Income | -52.05M | 89.37M | -38.35M | 17.00M | 62.81M | 55.45M | 1.22M | 34.44M | 50.32M | 45.07M | 88.56M | 69.06M | 54.46M | 83.03M | 53.02M | 58.11M | 50.38M | 79.69M | 44.43M | 57.14M | 41.80M |
| Operating Income Ratio | -8.17% | 12.24% | -7.00% | 3.83% | 12.70% | 8.68% | 0.19% | 5.79% | 9.78% | 8.02% | 12.60% | 10.57% | 8.78% | 16.10% | 13.76% | 13.89% | 12.68% | 24.79% | 47.75% | 60.00% | 46.80% |
| Total Other Income/Expenses | -6.53M | -1.73M | -1.42M | 153.00K | -257.00K | -853.00K | 29.00K | 364.00K | 687.00K | -3.15M | -6.96M | 3.17M | -8.01M | 3.97M | -3.08M | -9.07M | -9.69M | -5.34M | -1.66M | -4.09M | -2.74M |
| Income Before Tax | -58.58M | 87.64M | 84.41M | 17.15M | 62.55M | 54.60M | 1.24M | 34.80M | 51.01M | 41.92M | 81.60M | 59.33M | 46.45M | 86.99M | 49.94M | 49.05M | 40.70M | 74.35M | 41.18M | 53.82M | 39.06M |
| Income Before Tax Ratio | -9.20% | 12.01% | 15.40% | 3.86% | 12.65% | 8.54% | 0.20% | 5.85% | 9.91% | 7.46% | 11.61% | 9.08% | 7.49% | 16.87% | 12.96% | 11.72% | 10.24% | 23.13% | 44.26% | 56.52% | 43.73% |
| Income Tax Expense | 27.94M | 6.29M | 26.20M | 409.00K | 4.63M | 4.69M | -1.46M | 1.49M | 5.86M | 4.50M | 11.28M | 9.76M | 4.75M | 11.14M | 7.07M | 3.41M | 6.08M | 6.99M | 6.21M | 7.29M | 3.63M |
| Net Income | -86.06M | 81.42M | 58.32M | 16.83M | 58.30M | 50.53M | 3.38M | 33.17M | 45.27M | 37.22M | 69.99M | 49.46M | 41.11M | 75.77M | 43.20M | 45.93M | 34.65M | 67.36M | 34.97M | 46.53M | 35.43M |
| Net Income Ratio | -13.51% | 11.15% | 10.64% | 3.79% | 11.79% | 7.91% | 0.54% | 5.58% | 8.79% | 6.63% | 9.96% | 7.57% | 6.63% | 14.70% | 11.21% | 10.98% | 8.72% | 20.96% | 37.59% | 48.86% | 39.66% |
| EPS | -0.16 | 0.15 | 0.11 | 0.03 | 0.11 | 0.10 | 0.01 | 0.06 | 0.09 | 0.07 | 0.13 | 0.09 | 0.08 | 0.12 | 0.06 | 0.07 | 0.05 | 0.10 | 0.10 | 0.14 | 0.27 |
| EPS Diluted | -0.16 | 0.15 | 0.11 | 0.03 | 0.11 | 0.10 | 0.01 | 0.06 | 0.09 | 0.07 | 0.13 | 0.09 | 0.08 | 0.12 | 0.06 | 0.07 | 0.05 | 0.10 | 0.10 | 0.14 | 0.27 |
| Weighted Avg Shares Out | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 622.94M | 683.70M | 683.70M | 683.70M | 683.70M | 683.70M | 683.70M | 129.79M |
| Weighted Avg Shares Out (Dil) | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 529.70M | 622.94M | 683.70M | 683.70M | 683.70M | 683.70M | 683.70M | 683.70M | 129.79M |
Source: https://incomestatements.info
Category: Stock Reports